Alanna A. Morris

机构：Emory University, Bayer (United States), Bayer (Germany) · ORCID：0000-0002-8033-3707

发表论文 313 篇 · 总被引 7536 次 · h-index 46

代表论文

HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America (2024 · Journal of Cardiac Failure · 被引 424)
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial (2025 · The Lancet · 被引 84)
2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart Failure Focused Update (2024 · Journal of the American College of Cardiology · 被引 72)
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Data Standards (2024 · Circulation Cardiovascular Quality and Outcomes · 被引 41)
2024 ACC/AHA Key Data Elements and Definitions for Social Determinants of Health in Cardiology (2024 · Journal of the American College of Cardiology · 被引 24)
Recognition of the Large Ambulatory C2D Stage of Advanced Heart Failure—A Call to Action (2025 · JAMA Cardiology · 被引 20)